These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 3743419)

  • 1. Precautions in the use of Michaelis-Menten kinetics in the prediction of phenytoin levels.
    Jochsberger T
    Drug Intell Clin Pharm; 1986; 20(7-8):605-6. PubMed ID: 3743419
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phenytoin pharmacokinetic analysis and steady-state level prediction using a programmable calculator.
    Ng PK
    Int J Biomed Comput; 1980 Jul; 11(4):329-034. PubMed ID: 7399737
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of bioavailability on the calculated Michaelis-Menten parameters of phenytoin in children.
    Koren G; Brand N; MacLeod SM
    Ther Drug Monit; 1984; 6(1):11-4. PubMed ID: 6710554
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative evaluation of six techniques for determining the Michaelis-Menten parameters relating phenytoin dose and steady-state serum concentrations.
    Mullen PW; Foster RW
    J Pharm Pharmacol; 1979 Feb; 31(2):100-4. PubMed ID: 33239
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rapid and slow release phenytoin in epileptic patients at steady state: assessment of relative bioavailability utilizing Michaelis-Menten parameters.
    Sawchuk RJ; Pepin SM; Leppik IE; Gumnit RJ
    J Pharmacokinet Biopharm; 1982 Aug; 10(4):383-91. PubMed ID: 7153871
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analytical approximations of sensitivities of steady state predictions to errors in parameter estimation: II. Michaelis-Menten kinetics.
    Gonda I
    J Pharmacokinet Biopharm; 1984 Oct; 12(5):525-34. PubMed ID: 6520746
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Apparent Michaelis-Menten kinetic parameters of phenytoin in pediatric patients.
    Chiba K; Ishizaki T; Miura H; Minagawa K
    Pediatr Pharmacol (New York); 1980; 1(2):171-80. PubMed ID: 7346739
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Individualizing phenytoin dosage regimens using a programmable calculator.
    Ng PK
    Am J Hosp Pharm; 1980 Apr; 37(4):529-33. PubMed ID: 7377216
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phenytoin--allopurinol interaction: Michaelis--Menten kinetic parameters of phenytoin with and without allopurinol in a child with Lesch--Nyhan syndrome.
    Yokochi K; Yokochi A; Chiba K; Ishizaki T
    Ther Drug Monit; 1982; 4(4):353-7. PubMed ID: 7157458
    [TBL] [Abstract][Full Text] [Related]  

  • 10. First-pass effect: nonlinear concept comprising an explicit solution of integrated Michaelis-Menten equation.
    Keller F; Scholle J
    J Pharm Sci; 1981 Feb; 70(2):195-8. PubMed ID: 7205226
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phenytoin Michaelis-Menten pharmacokinetics in Caucasian paediatric patients.
    Bauer LA; Blouin RA
    Clin Pharmacokinet; 1983; 8(6):545-9. PubMed ID: 6653035
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New and simple method to predict dosage of drugs obeying simple Michaelis-Menten elimination kinetics and to distinguish such kinetics from simple first order and from parallel Michaelis-Menten and first order kinetics.
    Wagner JG
    Ther Drug Monit; 1985; 7(4):377-86. PubMed ID: 4082237
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Population pharmacokinetics of phenytoin in South African black patients.
    Miller R; Rheeders M; Klein C; Suchet I
    S Afr Med J; 1987 Aug; 72(3):188-90. PubMed ID: 3603312
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Michaelis-Menten kinetics and the steady-state serum phenytoin/hydroxyphenytoin ratio.
    Bourgeois BF; Wad N
    Ther Drug Monit; 1985; 7(4):405-10. PubMed ID: 4082240
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Population kinetic program for Michaelis-Menten elimination].
    Lü M; Zhou HW; Song JF
    Zhongguo Yao Li Xue Bao; 1990 Jan; 11(1):85-8. PubMed ID: 2403022
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phenytoin and folic acid interaction: a preliminary report.
    Berg MJ; Fischer LJ; Rivey MP; Vern BA; Lantz RK; Schottelius DD
    Ther Drug Monit; 1983; 5(4):389-94. PubMed ID: 6659012
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of four single-point phenytoin dosage prediction techniques using computer-simulated pharmacokinetic values.
    Toscano JP; Jameson JP
    Clin Pharm; 1986 May; 5(5):396-402. PubMed ID: 3720209
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Classical Michaelis-Menten and system theory approach to modeling metabolite formation kinetics.
    Popović J
    Eur J Drug Metab Pharmacokinet; 2004; 29(3):205-14. PubMed ID: 15537173
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of a nomogram for estimating the rate of phenytoin accumulation.
    Levine M; Orr J; Chang T
    Ther Drug Monit; 1987 Jun; 9(2):166-70. PubMed ID: 3617155
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predicting individual phenytoin dosage.
    Vozeh S; Muir KT; Sheiner LB; Follath F
    J Pharmacokinet Biopharm; 1981 Apr; 9(2):131-46. PubMed ID: 7277205
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.